Your browser doesn't support javascript.
loading
Psoriasiform eruptions secondary to phosphoinositide 3-kinase inhibition.
Dewan, Anna K; Gupta, Sameer; Bach, Daniel Q; Jadeja, Saagar; Granter, Scott; LaCasce, Ann; Joyce, Robin; Davids, Matthew S; Huang, Victor; LeBoeuf, Nicole R.
Affiliation
  • Dewan AK; Department of Dermatology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Gupta S; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
  • Bach DQ; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
  • Jadeja S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • Granter S; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.
  • LaCasce A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Joyce R; Department of Medical Oncology, Beth Israel Deaconess Medical Center, Boston, Massachusetts.
  • Davids MS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
  • Huang V; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
  • LeBoeuf NR; Department of Dermatology, The Center for Cutaneous Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
JAAD Case Rep ; 5(5): 401-405, 2019 May.
Article in En | MEDLINE | ID: mdl-31049381

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Case Rep Year: 2019 Document type: Article Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: JAAD Case Rep Year: 2019 Document type: Article Country of publication: Estados Unidos